The Europe pharmaceutical continuous manufacturing gravimetric feeder market is estimated to rise with a CAGR of 9.33% during the forecasted period of 2022 to 2030, reaching a revenue share of $28.51 million by 2030.

The market growth of the region is reinforced by the presence of leading pharmaceutical companies, substantial investments in pharmaceutical research and development (R&D), and the continual expansion of leading players. However, the Europe pharmaceutical continuous manufacturing gravimetric feeder market growth is likely to be restrained because of the strict regulations imposed on the pharmaceutical sector by the European Medicines Agency (EMA).

To know more about this report, request a free sample copy

The Europe pharmaceutical continuous manufacturing gravimetric feeder market growth includes a detailed study of the United Kingdom, Germany, France, Belgium, Italy, Spain, Poland, and Rest of Europe. The pharmaceutical sector in the United Kingdom represents 2.5% of the global pharmaceutical sales. GlaxoSmithKline Plc and AstraZeneca Plc are among the two major pharmaceutical companies operating in the United Kingdom.

R&D continues to be a key growth sector in the United Kingdom, with $191 million in state funding assigned to medication, advanced therapy, as well as vaccine development and manufacturing until the year 2023. As per the Office for National Statistics (ONS), pharmaceutical R&D accounts for nearly 27% of the country’s overall manufacturing R&D.

On the other hand, Germany is one of the top exporters of novel biopharmaceuticals in response to the international demand for personalized medicine. The nation’s long-standing strength of the local chemical sector and the high-performing industrial infrastructure, in addition to a highly-skilled workforce, further contribute to the pharmaceutical industry’s growth in Germany. Hence, the country’s proliferating pharmaceutical industry is set to bolster the need for pharmaceutical continuous manufacturing gravimetric feeders.

In France, the COVID-19 pandemic raised awareness of the country’s dependency on other nations for pharmaceutical supplies. Consequently, France began increasing its investment in the pharmaceutical businesses in order to tackle future health crises. Continuous manufacturing is also gaining immense traction in terms of API production since it grants numerous advantages over conventional batch manufacturing. These include increased process safety, improved productivity, better reaction control, reduced energy and solvent consumption, and reduced exposure for personnel. Hence, these factors are projected to augment the Europe pharmaceutical continuous manufacturing gravimetric feeder market growth during the forecast period.

The Europe pharmaceutical continuous manufacturing gravimetric feeder market is segmented into type. The type category is further segmented into twin screw gravimetric feeder and single screw gravimetric feeder. Twin screw gravimetric feeders provide relatively higher feeding accuracy compared to single screw gravimetric feeders. Hence, owing to this factor, they are increasingly used in the pharmaceutical industry. Twin screw gravimetric feeders are also available in a wide range of sizes, integrated with valuable options in order to solve material handling problems and meet the feed rate requirements.

Top players operating in the Europe pharmaceutical continuous manufacturing gravimetric feeder market include Brabender GmbH & Co KG, Coperion GmbH, Gimat Srl, etc.

Coperion GmbH, headquartered in Germany, provides industrial machinery. The company also offers auxiliary and weighing equipment, plastic manufacturing and processing plants, feeders, valves, and other machinery. With 10 manufacturing sites globally, Coperion GmbH operates in 30 locations.

The company’s single screw feeders are optimum for feeding free-flowing bulk materials, including pellets and powders.

Report Synopsis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.